Cited by 962Antimicrobial Resistance in StaphylococcusAntibiotic Resistance in BacteriaAntibiotic Use and Resistance

The DOI matches its Crossref record; 405 of the 406 references it cites were found in a registry or an index.

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Open access

Howden, Benjamin P., Davies, John K., Johnson, Paul D. R., Stinear, Timothy P., Grayson, M. Lindsay·2010·Clinical Microbiology Reviews

DOI 10.1128/cmr.00042-09PMC PMC2806658

Open this paper in CoChat — free account

Abstract

SUMMARY: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms. Recent data show that these strains have been detected globally and in many cases are associated with glycopeptide treatment failure; however, more rigorous clinical studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes. It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary. Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections. Given the subtleties of vancomycin susceptibility testing against S. aureus , it is imperative that diagnostic laboratories use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00042-09

Cites

405 of 405 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Osteomyelitis
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,988
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide Emergence
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
The Changing Epidemiology of Staphylococcus aureus ?
Chambers, H. F. “. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010204 · Cited by 1,419
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
Diekema, D. J., Pfaller, M. A., Schmitz, F., Smayevsky, J., Bell, J. M., Jones, R. N., Beach, M. L., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,363

Show all 406 references

Research works printed but not linked: 1

Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J.90:1113.

Sorted by citations

Items 701–800 of 962

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil
Stohs, E. J., Alexander, B. T., Fey, P. D., Foreman, M. C. L., Xu, L., Penewit, K. M., Waalkes, A., Salipante, S. J., & Werth, B. J. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag074 · Cited by 4
The role of nitric oxide synthase in biofilm formation by Staphylococcus aureus
Huang, Y., Cheng, Y., Shi, Y., Wang, X., Aghmiuni, S. K., Serwat, A., Zhang, Z., Shu, X., & Sun, B. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00870-z · Cited by 4
Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus
Guignard, B., Majcherczyk, P. A., Monachon, C., Vouillamoz, J., & Moreillon, P. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.028 · Cited by 4
Recent Epidemiological Changes in Infectious Diseases
Pucci, M. J., Callebaut, C., Cathcart, A. L., & Bush, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12405-9 · Cited by 4
The novel combinations of CTB, CpG, and aluminum hydroxide significantly enhanced the immunogenicity of clumping factor A 221-550 ofStaphylococcus aureus
Ma, J., Wang, B., Yu, L., Song, B., Yu, Y., Wu, S., Dong, Y., Zhu, Z., & Cui, Y. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1771170 · Cited by 4
The importance of targeting intraoperative transmission of bacteria with antibiotic resistance and strain characteristics
Loftus, R. W., Dexter, F., & Brown, J. R. (2022) · American Journal of Infection Control · doi:10.1016/j.ajic.2022.07.024 · Cited by 4
Molecular Characteristics and Prevalence of Rifampin Resistance in Staphylococcus aureus Isolates from Patients with Bacteremia in South Korea
Kim, Y. K., Eom, Y., Kim, E.-S., Chang, E., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Kim, S., Choi, S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12101511 · Cited by 4
Detection of Vancomycin Resistant Genes in Intrinsically Antibiotic Resistant Bacteria from the Gut Microbiota of Indonesian Individuals.
Luqman, A., Saising, J., Prasetya, Y. A., Ammanath, A. V., Andini, Amala, S. N., Zulaika, E., Kuswytasari, N. D., Goetz, F., & Wibowo, A. T. (2024) · PubMed Central · doi:10.30476/ijms.2023.98767.3087 · Cited by 4
Screening and characterization of antagonistic Streptomyces sp. JS20 from marine sediment in Vaan Island
Somasundaram, S., Arulmani, S. R. B., & Govindarajan, G. (2024) · The Microbe · doi:10.1016/j.microb.2024.100106 · Cited by 4
Simple Imaging System for Label‐Free Identification of Bacterial Pathogens in Resource‐Limited Settings
Douarre, C., David, D., Fangazio, M., Picard, E., Hadji, E., Vandenberg, O., Barbé, B., Hardy, L., & Marcoux, P. R. (2024) · International Journal of Biomedical Imaging · doi:10.1155/2024/6465280 · Cited by 4
Vancomycin‐intermediate Staphylococcus aureus employs CcpA‐GlmS metabolism regulatory cascade to resist vancomycin
Peng, H., Rao, Y., Shang, W., Yang, Y., Tan, L., Liu, L., Hu, Z., Wang, Y., Huang, X., Liu, H., et al. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.70007 · Cited by 4
Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin
McMullen, A. R., Lainhart, W., Wallace, M. A., Shupe, A., & Burnham, C. D. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03683-z · Cited by 4
Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
Hesketh, A. R., Bucca, G., Smith, C. P. S., & Hong, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.641756 · Cited by 4
Development of a Single-nucleotide Polymorphism Genotyping Assay for the Rapid Detection of Vancomycin-intermediate Resistance in Staphylococcus aureus Epidemic Lineage ST5
Kim, J. W., & Lee, K. J. (2023) · Annals of Laboratory Medicine · doi:10.3343/alm.2023.43.4.355 · Cited by 4
A Staphylococcus capitis strain with unusual bacteriocin production
Szekat, C., Josten, M., Rickmeyer, J., Crüsemann, M., & Bierbaum, G. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14356 · Cited by 3
Anti-infective Drug Development for MRSA
Daniel, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_17 · Cited by 4
Daptomycin-Tobramycin Cement Beads have Lethal Local Antibacterial Effect in Resistant Periprosthetic Joint Infections
Jagadale, V. S., Achilike, R., & Nord, K. M. (2019) · Cureus · doi:10.7759/cureus.5726 · Cited by 4
Aerogels as microbial disinfectant
Oves, M., Rauf, M. A., Warsi, M. K., Husain, F. M., Ansari, M. O., & Ismail, I. M. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820732-1.00011-4 · Cited by 5
Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
Hadder, B. A., Dexter, F., Robinson, A. D. M., & Loftus, R. W. (2022) · Infection Prevention in Practice · doi:10.1016/j.infpip.2022.100249 · Cited by 4
Papel de la daptomicina en el tratamiento de las infecciones en el paciente oncohematológico
Salavert, M., & Calabuig, E. (2010) · Medicina Clínica · doi:10.1016/s0025-7753(10)70039-7 · Cited by 4
Detection of the cell wall-affecting antibiotics at sublethal concentrations using a reporter Staphylococcus aureus harboring drp35 promoter - lacZ transcriptional fusion
Mondal, R., Chanda, P. K., Bandhu, A., Jana, B., Lee, C. Y., & Sau, S. (2010) · BMB Reports · doi:10.3858/bmbrep.2010.43.7.468 · Cited by 4
Antibiotic Resistance in Endophthalmitis Pathogens
Bispo, P. J. M., Selleck, E. M., & Gilmore, M. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-29231-1_14 · Cited by 4
Bacterial Cell Wall: Morphology and Biochemistry
Fisher, J. F., & Mobashery, S. (2015) · CRC Press eBooks · doi:10.1201/b17871-17 · Cited by 4
Aortic Root Abscess with Aorta to Right Atrium Fistula due to Vancomycin-Intermediate Staphylococcus aureus (VISA)
Hankinson, S. J., Sultanik, E. A., & Ramani, G. V. (2019) · Case Reports in Cardiology · doi:10.1155/2019/3627063 · Cited by 4
Synergistic Activity of Silver Nanoparticles and Vancomycin Against a Spectrum of Staphylococcus aureus Biofilm TypesPreprint
Hair, B. B., Conley, M. E., Wienclaw, T. M., Conley, M. J., & Berges, B. K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/337436 · Cited by 4
Stress-driven emergence of heritable non-genetic drug resistancePreprint
Xie, J. L., Yin, S., Yang, T. S., Chandrasekher, K. A., Hanson, L., Kim, S. H., Esqueda, L., Hogan, C. A., Banaei, N., Round, J. L., et al. (2024) · Research Square · doi:10.1101/2024.12.20.629823 · Cited by 4
Novel Approaches to Label the Surface of S. aureus with DBCO for Click Chemistry-Mediated Deposition of Sensitive Cargo
Baryakova, T. H., Hsu, C., Segatori, L., & McHugh, K. J. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00575 · Cited by 3
Emerging Antimicrobial Strategies Against Heterogeneous and Vancomycin-Intermediate Staphylococcus aureus
Wang, Y., Sun, Y., Chen, G., & Cheng, X. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s532471 · Cited by 3
Nitric Oxide-Releasing S-Nitrosoglutathione-Conjugated TEMPO-Oxidized Nanocellulose Hydrogel for the Treatment of MRSA-Infected Wounds
Kwak, D., Dagar, C., Kim, J. H., Lee, J., Kim, H., Ullah, M., Hakim, M. L., Kim, M.-J., Yeasmin, M. S., Nyalali, N., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121623 · Cited by 3
Green one pot synthesis of silver nanoparticles for antioxidant and antimicrobial activities
Moond, M., Singh, S., Sangwan, S., & Kumari, S. (2026) · Discover Nano · doi:10.1186/s11671-026-04529-2 · Cited by 3
First detected isolate of glycopeptide-intermediate resistantStaphylococcus aureusin a renal unit at a central academic hospital in Kwazulu-Natal
Swe-Han, K. S., Naidoo, N., Mahabeer, P., & Mlisana, K. P. (2013) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2013.11441532 · Cited by 3
The Changing Epidemiology and Antimicrobial Susceptibility of Staphylococcus aureus Isolated from Blood Cultures in a University Hospital from Argentina
Gulone, L., Gregorio, S. D., Morales, M. M., Haim, M. S., García, S. D., Perazzi, B. E., Famiglietti, A. M. R., & Mollerach, M. E. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0219 · Cited by 3
Herbal Bioactive Compounds for Skin Infections and Inflammatory Conditions
Tirant, M., Tirant, H., & Wollina, U. (2024) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2024.11888 · Cited by 3
Tracking Vancomycin MIC Creep: A Five Year Analysis
Devhare, D. P., Thakar, V. H., Kumar, M., Jadhavar, S., Modak, M. S., & Bhatawadekar, S. M. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.3.36 · Cited by 3
Investigation of Antibiotic Resistance of E. coli Associated with Farm Animal Feces with Participation of Citizen Scientists
Timofeeva, A. M., Galyamova, M. R., Krivosheev, D. M., Karabanov, S. Y., & Sedykh, S. E. (2024) · Microorganisms · doi:10.3390/microorganisms12112308 · Cited by 4
Identification of a distinctive phenotype for endocarditis-associated clonal complex 22 MRSA isolates with reduced vancomycin susceptibility
Marbach, H., Boakes, E., Lynham, S., Ward, M. A., Otter, J. A., & Edgeworth, J. D. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000470 · Cited by 3
Reports of Vancomycin-Resistant Staphylococcus aureus from Middle East Countries
Rahimipour, F., Ghazvini, K., & Youssefi, M. (2018) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.59522 · Cited by 3
Simulating Bacterial Growth, Competition, and Resistance with Agent-Based Models and Laboratory Experiments
Yust, A. E., & Smyth, D. S. (2020) · Foundations for undergraduate research in mathematics · doi:10.1007/978-3-030-33645-5_5 · Cited by 3
Mechanisms and Detection of Antimicrobial Resistance
Alby, K., & Miller, M. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00290-1 · Cited by 3
Teicoplanin-Resistant Coagulase-Negative Staphylococci: Do the Current Susceptibility Testing Methods Reliably Detect This Elusive Phenotype?
Balasiu, A., & MacKenzie, C. R. (2023) · Antibiotics · doi:10.3390/antibiotics12030611 · Cited by 3
Combatting Antibiotic-Resistant Staphylococcus aureus: Discovery of TST1N-224, a Potent Inhibitor Targeting Response Regulator VraRC, through Pharmacophore-Based Screening and Molecular Characterizations
Hsu, Y.-C., Liu, C. Q., Wu, Y., Lai, S.-J., Lin, C.-J., & Tseng, T. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01046 · Cited by 3
Genetic and Phenotypic Identification of Vancomycin-Resistant Staphylococcus aureus Isolates from Retail Poultry Carcasses in Omu-Aran, North-Central Nigeria
Okolie, C. E., Essien, U., & Idoko, J. (2015) · British Biotechnology Journal · doi:10.9734/bbj/2015/13145 · Cited by 3
Efficacy and safety of optional parenteral antimicrobial therapy for complicated skin and soft tissue infections: A systematic review and Bayesian network meta-analysis
Li, H., Liang, X., Mo, G., Guo, S., Chen, X., & Li, Y. (2022) · Medicine · doi:10.1097/md.0000000000030120 · Cited by 3
Low prevalence of vancomycin heteroresistance among meticillin-resistant Staphylococcus aureus causing bacteraemia in Hong Kong
Ho, P., Siu, J. T. P., Law, P. Y.-T., Lai, E. L.-Y., Tse, C. W. S., Lee, R., Kao, R. Y. T., Cheng, V. C., & Que, T. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.07.008 · Cited by 3
Antibiotic susceptibility and multiplex PCR analysis of Coagulase Negative Staphylococci isolated from laboratory workers
Thomas, S. A., Sugathan, S., & Mathew, J. (2013) · Cited by 3
VANCOMYCIN SENSITIVITY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) ISOLATES COLLECTED FROM CLINICAL SPECIMENS OF TABRIZ IMAM REZA AND SINA HOSPITALS BY E-TEST METHOD, AGAR SCREENING PLATE AND PCR
Bohlouli, P., Reza, N. M., Farajnia, S., Varshochi, M., Ghojazadeh, M., Mohammad, A. D., & Firouzeh, S. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
Ramos, J. R., Vidal, P., Díaz-Lamas, A. M., Reig-Valero, R., Roche‐Campo, F., del Valle-Ortiz, M., Nuvials, X., Piquer, M. O., Andaluz‐Ojeda, D., Tamayo-Lomas, L., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2970-3 · Cited by 3
Treatment of methicillin-resistantStaphylococcus aureusinfections: Importance of high vancomycin minumum inhibitory concentrations
Morales‐Cartagena, A. (2015) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v5.i2.14 · Cited by 3
Staphylococcus aureus bacteremia in a secondary level Spanish hospital: clinical implications of high vancomycin MIC.
Abelenda-Alonso, G., Corbacho-Loarte, M. D., Núñez Ramos, R., Jiménez, M. C., & Ruiz-Capillas, J. J. J. (2018) · Europe PMC (PubMed Central) · Cited by 3
Commentary: Identification of Low-Level Vancomycin Resistance in Staphylococcus aureus in the Era of Informatics
Ford, B. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00071-16 · Cited by 3
Raman spectra identify vancomycin-resistant phenotypes and their transcriptomic features in Staphylococcus aureus
Kamei, K.-I. F., Okura, R., Kobayashi-Kirschvink, K. J., Yamaguchi, T., Katayama, Y., & Wakamoto, Y. (2026) · mBio · doi:10.1101/2024.05.12.593718 · Cited by 3
Analysis of Staphylococcus aureus infections among pediatric Indian patients
Rajan, P., Chaudhary, N., Sanklecha, M., Wanjari, M. B., Sangoi, L., & Sangoi, R. (2024) · Bioinformation · doi:10.6026/9732063002001275 · Cited by 2
Microbial community and immune modulation enable effective treatment of methicillin-resistant Staphylococcus aureus skin infections with linalool
Xiong, X., Wen, X., Zhang, Y., Li, X., Zhang, Y., & Long, N. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107406 · Cited by 2
Characterisation of in vitro resistance selection against second-/last-line antibiotics in methicillin-resistant Staphylococcus aureus ATCC 43300 strain
Prasetyoputri, A., Pitt, M. E., Cao, M. D., Ramu, S., Kavanagh, A. M., Elliott, A. G., Ganesamoorthy, D., Monk, I. R., Stinear, T. P., Cooper, M. A., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf108 · Cited by 2
Self-citation
The toxin–antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening
Xu, W., Yan, P., Li, Y., & Sun, B. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf325 · Cited by 2
Genomic epidemiology of antimicrobial resistance in Staphylococcus aureus : Analysis of 1,152 complete genomes
Durairaj, E., Rajbongshi, J., & Vincent, M. (2025) · Journal of Laboratory Physicians · doi:10.25259/jlp_200_2025 · Cited by 2
In Silico Lead Identification of Staphylococcus aureus LtaS Inhibitors: A High-Throughput Computational Pipeline Towards Prototype Development
Khzem, A. H. A., Shoaib, T. H., Mukhtar, R. M., Alturki, M. S., Gomaa, M. S., Hussein, D. A., Mostafa, A., Alrumaihi, L. A., AlAnsari, F., & Laabei, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412038 · Cited by 2
Wastewater and urban waterways as hotspots for multidrug-resistant Staphylococcus aureus and Staphylococcus epidermidis in Yaoundé, Cameroon
Arfao, A. T., Manouore, A. N., Tchakonté, S., Onana, F. M., Hei, A. N., Yogne, Y. P., Nana, P. A., & Nola, M. (2025) · Cleaner Water · doi:10.1016/j.clwat.2025.100164 · Cited by 2
Staphylococcal accessory regulator SarA-mediated modulation of autolysis and surface charge enables Staphylococcus aureus to evade vancomycin killing
Li, Y., Yuan, S., Yan, P., Zhai, S., He, Z., Su, H., Zhu, Z., He, Q., Xu, W., & Sun, B. (2026) · mSystems · doi:10.1128/msystems.01630-25 · Cited by 2
The Comparison ofStaphylococcus aureusIsolated From Blood and Wound Specimens for Genes Encoding Polysaccharide Intercellular Adhesion (PIA)
Ghasemian, A., Peerayeh, S. N., & Bakhshi, B. (2015) · Avicenna Journal of Clinical Microbiology and Infection · doi:10.17795/ajcmi-25171 · Cited by 2
Characterization of the phenotypes of methicillin- and vancomycin-susceptible Staphylococcus argenteus after vancomycin passages
Chang, C., Lee, S., Lin, Y., Hsu, C., Cheng, C.-C., Teng, S.-H., Chen, M., Hsieh, P., Chang, Y., & Chiang-Ni, C. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.08.006 · Cited by 2
Sustainable Antimicrobial Nanomaterials: A Promising Treatment for Multiple Drug Resistant Microorganisms
Raut, N., Musle, R., Raut, M., Kanchhul, R. M., Taywade, E., & Umekar, M. J. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.57.4.115 · Cited by 3
Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus
van Hal, S. J., Jensen, S. O., Tong, S. Y. C., Bentley, S. D., & Holden, M. T. G. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae048 · Cited by 2
The 3′ UTR of vigR is required for virulence in Staphylococcus aureus and has expanded through STAR sequence repeat insertions
Mediati, D. G., Dan, W., Lalaouna, D., Dinh, H., Pokhrel, A., Rowell, K. N., Michie, K. A., Stinear, T. P., Cain, A. K., & Tree, J. J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114082 · Cited by 2
Self-citation
Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials
Nguyen, A., Roy, J. J. S., Kim, J.-H., Yun, K., Lee, W., Kim, K. K., Kim, T., & Chaurasia, A. K. (2024) · The Journal of Microbiology · doi:10.1007/s12275-024-00139-8 · Cited by 2
Vancomycin versus teicoplanin in the treatment of serious Gram-positive infections: what do the minimum inhibitory concentration data tell us?
Lowman, W. (2014) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2014.11441582 · Cited by 2
Laboratory Detection of Vancomycin Nonsusceptible Staphylococcus aureus
Burnham, C. D., Craven, R. R., & Dunne, W. M. (2011) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc1706s22 · Cited by 2
INCIDENCES OF STAPHYLOCOCCUS SPECIES IN SURGICAL SITE INFECTIONS-PROSPECTIVE STUDY FROM TERTIARY CARE CENTER, COIMBATORE, TAMILNADU
Amutha, B., & Viswanathan, T. (2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 2
Study of Decreased Susceptibility to Vancomycin in Methicillin-Resistant Staphylococcus aureus Strains isolated from a Romanian Multidisciplinary Emergency Hospital
Vas, K. E., Izabella, S., Szabolcs, M., Lőrinczi, L. K., & Edit, S. (2014) · Revista română de medicină de laborator · doi:10.2478/rrlm-2014-0013 · Cited by 2
Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
Ramaraj, T., Matyi, S. A., Sundararajan, A., Lindquist, I. E., Devitt, N. P., Schilkey, F., Lamichhane-Khadka, R., Hoyt, P. R., Mudge, J., & Gustafson, J. E. (2014) · Genome Announcements · doi:10.1128/genomea.01033-14 · Cited by 2
Frequency of Reduced Vancomycin Susceptibility among Clinical Staphylococcus aureus Isolated in Ahvaz Iran
Moosavian, M., & Torabipour, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Staphylococcus aureus with reduced vancomycin susceptibility among clinical isolates in Erbil City
Taha, A. B. (2014) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2014.0010 · Cited by 1
Methicillin-Resistant Staphylococcus aureus: A Review of Current Antibiotic Therapy
Snider, J. D., Rivard, B. M., & Specialist, P. (2012) · Cited by 2
Les bactéries à Gram positives multirésistantes : probabilités de résistance ? Que craindre ?
Lina, G., & Cattoir, V. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31312-3 · Cited by 2
Tratamiento de las infecciones por Staphylococcus aureus
Carmona-Torre, F., & del Pozo, J. L. (2018) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2018.02.007 · Cited by 2
Staphylococcus aureus vaccines
Daum, R. S. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00060-4 · Cited by 2
Overcoming antimicrobial resistance by nanoparticles
Mahboubi, A., Moghimi, H. R., Mortazavi, S. M., Gorji‐Bahri, G., & Gandomkarzadeh, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90792-7.00018-x · Cited by 2
Leuconostoc lactis Bacteremia and Neutropenic Fever
Bush, L. M., & Williams, J. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001234 · Cited by 2
Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Tertiary Care Hospitals in South India
Sreejisha, M., Shalini Shenoy, M., Shenoy, S. M., Dhanashree, B., Mahabala, C., & Gopalakrishna Bhat, K. (2023) · Sultan Qaboos University medical journal · doi:10.18295/squmj.3.2023.018 · Cited by 2
Identification and Characterization of a Vancomycin Intermediate-Resistant Staphylococcus haemolyticus Isolated from Guangzhou, China
Dong, W., Qi, P., Tang, X., Zhong, T., Lin, S., Zhi, Z., Ye, J., Yang, B., Sun, N., & Yuan, W. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s411860 · Cited by 2
Antibiotic Resistance – Where are We Going?
Hryniewicz, W., & Strużycka, I. (2023) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2023-0007 · Cited by 5
Staphylococcal Infection
Tatara, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-39474-4_2 · Cited by 2
COMPARISON OF ETEST AND AGAR DILUTION FOR DETERMINING MINIMUM INHIBITORY CONCENTRATION OF VANCOMYCIN TO HEALTHCARE-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Bhat, K. G., Kumari, J., Shenoy, S. M., Mahabala, C., & Vidyalakshmi, K. (2016) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 2
Biofilm formation and antibiotic resistance on alginate beads of Staphylococcus aureus and other health care associated bacterial species
Wilkinson, A. J. (2016) · ERA · Cited by 2
Staphylococcal prosthetic joint infections : similar, but still different
Tevell, S. (2019) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Staphylococcus , Micrococcus , and Other Catalase‐Positive Cocci
Becker, K., David, M. Z., & Skov, R. L. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0021 · Cited by 4
Simple sequence repeats power Staphylococcus aureus adaptationPreprint
Guérillot, R., Hayes, A. S., Hachani, A., Giulieri, S. G., Donovan, L., Judd, L. M., Sharkey, L. K. R., da Silva, A. G., Seemann, T., Stinear, T. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663602 · Cited by 3
Self-citation
Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus
Chaudhary, B. L., Bisht, D., & Faujdar, S. S. (2022) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.4103/ajprhc.ajprhc_14_21 · Cited by 1
Profiling the in vivo RNA interactome associated with the endoribonuclease RNase III in Staphylococcus aureus
Wu, W., Pang, C. N. I., Tree, J. J., & Mediati, D. G. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.05.001 · Cited by 1
Antimicrobial Synergistic Effects of Linezolid and Vancomycin with a Small Synthesized 2-Mercaptobenzothiazole Derivative: A Challenge for MRSA Solving
Muraglia, M., Schiavone, B. I. P., Rosato, A., Clodoveo, M. L., & Corbo, F. (2023) · Molecules · doi:10.3390/molecules28176348 · Cited by 1
Effects of Vancomycin Subtherapeutic Concentration on Staphylococcus aureus Isolated from Hemodialysis Patients with Low Serum Trough Concentrations
Chagas, R., Silva, C. D. S. E., Birro, J. D. C. T., & dos Santos, K. V. (2024) · Current Microbiology · doi:10.1007/s00284-023-03588-3 · Cited by 1
Microbiological Quality of Street Foods and Antimicrobial Resistance Pattern of Bacterial Isolates Including Assessment of Food Hygiene Knowledge of Food Handlers
Moli*, M. A., Deb, A., Shifat, S. K., Gulshan, A., & Alhadi, M. R. (2025) · American Journal of Pure and Applied Biosciences · doi:10.34104/ajpab.025.02210234 · Cited by 1
Methicillin-Resistant Staphylococcus epidermidis (MRSE): An Updated Narrative Review on its Epidemiology, Resistance Mechanisms, and Emerging Treatment Strategies
Ghosh, S., Singh, S., & Kaushik, P. (2025) · Anti-Infective Agents · doi:10.2174/0122113525388954250603114510 · Cited by 1
Effects of donor lung methicillin-resistant Staphylococcus aureus on lung transplantation outcomes: a single-center retrospective study
Takada, J., Kawashima, M., Yamaguchi, M., Yuhara, S., Yoshiyasu, N., Cong, Y., Nakao, K., Toyokawa, G., Hino, H., Konoeda, C., et al. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.07.013 · Cited by 1
Nanoengineered Carbon Dots for Enhanced Antibacterial Response and Sensitive Bacterial Sensing
Sudewi, S., Edy, H. J., Hariyanto, Y. A., Sashankh, P. V. S., Rasool, A., Zulfajri, M., Gedda, G., & Huang, G. G. (2025) · Luminescence · doi:10.1002/bio.70329 · Cited by 1
Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus haemolyticus Among Blood Isolates
Manoharan, M., Sistla, S., & Amberpet, R. (2025) · Microbial Drug Resistance · doi:10.1177/10766294251389588 · Cited by 1
The Roles of Carbon‐Nitrogen Synergy and Phosphate Regulation in Producing Higher Yield of Vancomycin by Amycolatopsis orientalis
Mani, V., Jeyachandran, S., & Aman, M. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70072 · Cited by 1
Abelmoschus Manihot flowers inhibit dysbiotic Enterobacteriaceae expansion by promoting Clostridium bolteae-mediated hypoxia restoration
Li, C., Wang, Y., Zhang, Q., Liang, H., Li, J., Zhang, S., Duan, J., & Guo, J. (2025) · Microbiome · doi:10.1186/s40168-025-02246-z · Cited by 1
Preparation of silibinin- dendrimer-stabilized Au nanoparticles for decreasing vancomycin resistance in S. aureus clinical isolates
Ahmadzadeh, M., Shahriarinour, M., Ranji, N., Divsar, F., & Mokhtary, M. (2026) · International Microbiology · doi:10.1007/s10123-025-00769-x · Cited by 1
Marine Bacteria as a Source of Antibiotics Against Staphylococcus aureus: Natural Compounds, Mechanisms of Action, and Discovery Strategies
Xuma, C., Bourles, A., Colot, J., Guentas, L., & Matsui, M. (2026) · Marine Drugs · doi:10.3390/md24010044 · Cited by 1

Authors: Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L.
Affiliations: The University of Melbourne (AU)
Monash University (AU)
ORCID: Howden, Benjamin P.
Johnson, Paul D. R.
Stinear, Timothy P.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 99-139
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00042-09
PMC: PMC2806658
OpenAlex: W2126915534
Cited by: 962
References: 406
Citations by year: 2026: 42 · 2025: 41 · 2024: 48 · 2023: 58 · 2022: 45 · 2021: 52 · 2020: 49 · 2019: 60 · 2018: 54 · 2017: 51 · 2016: 63 · 2015: 83 · 2014: 69 · 2013: 88 · 2012: 72
FWCI: 9.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords: vancomycin-intermediate Staphylococcus aureus, heterogeneous vancomycin-intermediate Staphylococcus aureus, reduced vancomycin susceptibility, glycopeptide resistance, cell wall thickening, agr gene, vancomycin susceptibility testing, treatment failure, host-pathogen interaction
MeSH terms: Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Treatment Outcome, Vancomycin Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks